Cargando…
Value of PCA3 to Predict Biopsy Outcome and Its Potential Role in Selecting Patients for Multiparametric MRI
PCA3 (prostate cancer gene 3) and multiparametric 3 tesla MRI are new promising diagnostic tools in the detection of PCa. Our aim was to study the clinical value of the Progensa PCA3-test: its predictive value for biopsy outcome, Gleason score and MRI outcome. We evaluated, retrospectively, 591 pati...
Autores principales: | Leyten, Gisele H. J. M., Wierenga, Elisabeth A., Michiel Sedelaar, J. P., van Oort, Inge M., Futterer, Jurgen J., Barentsz, Jelle O., Schalken, Jack A., Mulders, Peter F. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709735/ https://www.ncbi.nlm.nih.gov/pubmed/23759986 http://dx.doi.org/10.3390/ijms140611347 |
Ejemplares similares
-
High-risk prostate cancer: value of multi-modality 3T MRI-guided biopsies after previous negative biopsies
por: Fütterer, Jurgen J., et al.
Publicado: (2011) -
Prior PSMA PET-CT Imaging and Hounsfield Unit Impact on Tumor Yield and Success of Molecular Analyses from Bone Biopsies in Metastatic Prostate Cancer
por: Smits, Minke, et al.
Publicado: (2020) -
MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience
por: van de Ven, Wendy J. M., et al.
Publicado: (2016) -
Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men
por: Hendriks, Rianne J., et al.
Publicado: (2021) -
Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer
por: Fütterer, Jurgen J.
Publicado: (2017)